Jacky; Birgitte P S

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jacky; Birgitte P S.The latest application filed is for "botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin".

Company Profile

1.32.37

Jacky; Birgitte P S - Orange CA
Jacky; Birgitte P.S. - Orange CA
Jacky; Birgitte P. S. - Long Beach CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Botulinum toxin cell binding domain polypeptides and methods of use for skin rejuvenation Grant 11,149,262 - Jacky , et al. October 19, 2	2021-10-19
Botulinum Neurotoxin For Treatment Of Disorders Associated With Melanocyte Hyperactivity And/or Excess Melanin App 20210162027 - Jacky; Birgitte P.S. ; et al.	2021-06-03
Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin Grant 10,912,823 - Jacky , et al. February 9, 2	2021-02-09
Botulinum Neurotoxin For Treatment Of Disorders Associated With Melanocyte Hyperactivity And/or Excess Melanin App 20180344820 - Jacky; Birgitte P.S. ; et al.	2018-12-06
Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays App 20170218334 - Zhu; Hong ; et al.	2017-08-03
Cells useful for immuno-based botulinum toxin serotype A activity assays Grant 9,625,447 - Zhu , et al. April 18, 2	2017-04-18
Cells useful for immuno-based botulinum toxin serotype a activity assays Grant 8,691,566 - Zhu , et al. April 8, 2	2014-04-08
Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays App 20140093957 - Zhu; Hong ; et al.	2014-04-03
Cells useful for immuno-based botulinum toxin serotype A activity assays Grant 8,663,983 - Zhu , et al. March 4, 2	2014-03-04
Cells useful for immuno-based botulinum toxin serotype A activity assays Grant 8,663,982 - Zhu , et al. March 4, 2	2014-03-04
Cells useful for immuno-based botulinum toxin serotype A activity assays Grant 8,603,813 - Zhu , et al. December 10, 2	2013-12-10
Cells useful for immuno-based botulinum toxin serotype A activity assays Grant 8,603,812 - Zhu , et al. December 10, 2	2013-12-10
Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays App 20130236963 - Zhu; Hong ; et al.	2013-09-12
Methods Of Treating Cancer Using Opiod Retargeted Endopepidases App 20130230502 - Jacky; Birgitte P.S. ; et al.	2013-09-05
Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted Endopepidases App 20130224178 - Jacky; Birgitte P.S. ; et al.	2013-08-29
Cells useful for immuno-based botulinum toxin serotype A activity assays Grant 8,507,271 - Zhu , et al. August 13, 2	2013-08-13
Cells useful for immuno-based botulinum toxin serotype A activity assays Grant 8,501,469 - Zhu , et al. August 6, 2	2013-08-06
Methods of Treating Cancer Using Growth Factor Retargeted Endopeptidases App 20130195838 - JACKY; Birgitte P.S. ; et al.	2013-08-01
Botulinum toxin screening assays Grant 8,497,081 - Fernandez-Salas , et al. July 30, 2	2013-07-30
Cells useful for immuno-based botulinum toxin serotype A activity assays Grant 8,476,069 - Zhu , et al. July 2, 2	2013-07-02
Cells useful for immuno-based botulinum toxin serotype A activity assays Grant 8,476,068 - Zhu , et al. July 2, 2	2013-07-02
Cells useful for immuno-based botulinum toxin serotype A activity assays Grant 8,455,247 - Zhu , et al. June 4, 2	2013-06-04
Cells useful for immuno-based botulinum toxin serotype A activity assays Grant 8,455,213 - Zhu , et al. June 4, 2	2013-06-04
Cells useful for immuno-based Botulinum toxin serotype A activity assays Grant 8,455,248 - Zhu , et al. June 4, 2	2013-06-04
Cells useful for immuno-based Botulinum toxin serotype A activity assays Grant 8,361,789 - Zhu , et al. January 29, 2	2013-01-29
Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays App 20120214229 - Zhu; Hong ; et al.	2012-08-23
Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays App 20120214231 - Zhu; Hong ; et al.	2012-08-23
Inhibiting Aberrant Blood Vessel Formation Using Retargeted Endopeptidases App 20120207743 - Jacky; Birgitte P.S. ; et al.	2012-08-16
Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays App 20120208272 - Zhu; Hong ; et al.	2012-08-16
Methods of Inhibiting Aberrant Blood Vessel Formation Using Opioid Retargeted Endpeptidases App 20120207734 - Jacky; Birgitte P.S. ; et al.	2012-08-16
Inhibiting Aberrant Blood Vessel Formation Using Growth Factor Retargeted Endopeptidases App 20120207704 - Jacky; Birgitte P.S. ; et al.	2012-08-16
Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays App 20120208271 - Zhu; Hong ; et al.	2012-08-16
Treating a Disease of Hyperproliferation Using Retargeted Endopeptidases App 20120207733 - Jacky; Birgitte P.S. ; et al.	2012-08-16
Treatments Using PSMA Ligand Endopeptidases App 20120207742 - Jacky; Birgitte P.S. ; et al.	2012-08-16
Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays App 20120164728 - Zhu; Hong ; et al.	2012-06-28
Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays App 20120156769 - Zhu; Hong ; et al.	2012-06-21
Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays App 20120156775 - Zhu; Hong ; et al.	2012-06-21
Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays App 20120156776 - Zhu; Hong ; et al.	2012-06-21
Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays App 20120156774 - Zhu; Hong ; et al.	2012-06-21
Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays App 20120149106 - Zhu; Hong ; et al.	2012-06-14
Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays App 20120149104 - Zhu; Hong ; et al.	2012-06-14
Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays App 20120149103 - Zhu; Hong ; et al.	2012-06-14
Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays App 20120149105 - Zhu; Hong ; et al.	2012-06-14
Methods of Treating Cancer Using Tachykinin Retargeted Endopepidases App 20110110911 - Jacky; Birgitte P.S. ; et al.	2011-05-12
Methods Of Treating Cancer Using Neurotrophin Retargeted Endopeptidases App 20110070215 - Jacky; Birgitte P.S. ; et al.	2011-03-24
Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted Endopeptidases App 20110070212 - Jacky; Birgitte P.S. ; et al.	2011-03-24
Methods of Treating Cancer Using Galanin Retargeted Endopepidases App 20110070211 - JACKY; BIRGITTE P.S. ; et al.	2011-03-24
Methods of Treating Cancer Using Growth Factor Retargeted Endopeptidases App 20110070186 - Jacky; Birgitte P.S. ; et al.	2011-03-24
Methods of Treating Cancer Using Opioid Retargeted Endopepidases App 20110064713 - Jacky; Birgitte P.S. ; et al.	2011-03-17
Cells Useful For Immuno-based Botulinum Toxin Serotype A Activity Assays App 20100233802 - Zhu; Hong ; et al.	2010-09-16
Botulinum Toxin Screening Assays App 20090263836 - FERNANDEZ-SALAS; ESTER ; et al.	2009-10-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.